EXAMINE THIS REPORT ON HEMGENIX

Number of qualified clients: CDEC reviewed the uncertainty in the volume of clients with reasonably significant to critical hemophilia B in Canada qualified for etranacogene dezaparvovec. Clinical experts consulted by CADTH indicated that some individuals who are classified as owning moderate or reasonable ailment could have a serious bleeding phen